[HTML][HTML] Immune subgroup analysis for non-small cell lung cancer may be a good choice for evaluating therapeutic efficacy and prognosis
Y Tian, J Wang, Q Wen, G Su, Y Sun - Aging (Albany NY), 2021 - ncbi.nlm.nih.gov
Due to its effectiveness, cancer immunotherapy has attracted widespread attention from
clinicians and scientific researchers. Numerous studies have proven that effective …
clinicians and scientific researchers. Numerous studies have proven that effective …
[PDF][PDF] МОЛЕКУЛЯРНО-ГЕНЕТИЧЕСКИЕ МАРКЕРЫ МЕТАСТАЗИРОВАНИЯ СВЕТЛОКЛЕТОЧНОГО ПОЧЕЧНО-КЛЕТОЧНОГО РАКА
ПВ Кононец - Москва, 2024 - ronc.ru
Рак почки представляет важную медицинскую проблему в связи со значительным
ростом заболеваемости [10]. Наиболее распространенным и агрессивным среди …
ростом заболеваемости [10]. Наиболее распространенным и агрессивным среди …
Tissue based biomarkers for metastatic clear cell renal carcinoma: A systematic review
AL Schmidt, PA Bain, BA McGregor - Kidney Cancer, 2020 - content.iospress.com
Background: Treatments for metastatic clear cell renal carcinoma (mccRCC) are evolving
with multiple targeted and immune therapy drugs currently approved by regulatory agencies …
with multiple targeted and immune therapy drugs currently approved by regulatory agencies …